Erratum: Effect of systemic administration of d-serine on the levels of d- and l-serine in several brain areas and periphery of rat (European Journal of Pharmacology (2004) 495 (153-158) DOI: 10.1016/j.ejphar.2004.05.036);Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat

European Journal of Pharmacology

Volumn 495, Issue 2-3, 2004, Pages 153-158

  Hashimoto, Atsushi ^a   Chiba, Yukie ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

D Amino acid oxidase; D Serine; Glycine site; L Serine; N Methyl D aspartate receptor; Serine racemase

Indexed keywords

DEXTRO SERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DIENCEPHALON; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG POTENCY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 3042757433     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.016     Document Type: Erratum

References (43)

1. Braunlich H. Postnatal development of kidney function in rats receiving thyroid hormones. Exp. Clin. Endocrinol. 83:1984;243-250
2. Carone F.A., Ganote C.E. D-Serine nephrotoxicity. Arch. Pathol. 99:1975;658-662
3. Chouinard M.L., Gaitan D., Wood P.L. Presence of the N-methyl-D- aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson and Alzheimer tissues. J. Neurochem. 61:1993;1561-1564
4. Contreras P.C. D-Serine antagonized phencyclidine- and MK-801-induced stereotypyed behavior and ataxia. Neuropharmacology. 29:1990;291-293
5. D'Aniello A., D'Onofrio G., Pischetola M., D'Aniello G., Vetere A., Petrucelli L., Fisher G.H. Biological role of D-amino acid oxidase and D-aspartate oxidase. J. Biol. Chem. 268:1993;26941-26949
6. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., Morihisa J.M. A "glutamatergic hypothesis" of schizophrenia, Rationale for Pharmacotherapy with glycine. Clin. Neuropharmacol. 12:1989;1-13
7. Dunlop D.S., Neidle A. The origin and turnover of D-serine in brain. Biochem. Biophys. Res. Commun. 235:1997;26-30
8. Fleck Ch. Renal transport of endogenous amino acids. Renal Physiol. Biochem. 15:1992;257-265
9. Ganote C.E., Peterson D.R., Carone F.A. The nature of D-serine-induced neprotoxicity. Am. J. Pathol. 77:1974;269-282
10. Hashimoto A. Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res. 955:2002;214-220
11. Hashimoto A., Oka T. Free D-aspartate and D-serine in the mammalian brain and periphery. Prog. Neurobiol. 52:1997;325-353
12. Hashimoto A., Nishikawa T., Oka T., Takahashi K. D-Alanine inhibits methamphetamine-induced hyperactivity in rats. Eur. J. Pharmacol. 202:1991;105-107
13. Hashimoto A., Nishikawa T., Hayashi T., Fujii N., Harada K., Oka T., Takahashi K. The presence of free D-serine in rat brain. FEBS Lett. 296:1992;33-36
14. Hashimoto A., Nishikawa T., Oka T., Takahashi K. Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J. Neurochem. 60:1993;783-786
15. Hashimoto A., Nishikawa T., Konno R., Niwa A., Yasumura Y., Oka T., Takahashi K. Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci. Lett. 152:1993;33-36
16. Hashimoto A., Oka T., Nishikawa T. Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience. 66:1995;635-643
17. Hashimoto A., Oka T., Nishikawa T. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Eur. J. Neurosci. 7:1995;1657-1663
18. Hashimoto A., Kanda J., Oka T. Effects of N-methyl-D-aspartate, kainate or veratridine on extracellular concentrations of free D-serine and L-glutamate in rat striatum: an in vivo microdialysis study. Brain Res. Bull. 53:2000;347-351
19. Hawkinson J.E., Acosta-Burruel M., Ta N.D., Wood P.L. Novel phosphoserine phosphatase inhibitors. Eur. J. Pharmacol. 337:1997;315-324
20. Horiike K., Tojo H., Arai R., Nozaki M., Maeda T. D-Amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652:1994;297-303
21. 14C-D- serine-administered intravenously to rats. Amino Acids. 15:1998;351-361
22. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308
23. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531
24. Kleckner N.W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241:1988;835-837
25. Konno R. Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus. Neurosci. Lett. 349:2003;111-114
26. Kumashiro S., Hashimoto A., Nishikawa T. Free D-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res. 681:1995;117-125
27. Lefauconnier J.M., Trouve R. Developmental changes in the pattern of amino acid transport at the blood-brain barrier in rats. Dev. Brain Res. 6:1983;175-182
28. Matsui T., Sekiguchi M., Hashimoto A., Tomita U., Nishikawa T., Wada K. Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65:1995;454-458
29. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 98:1999;427-436
30. Neims A.H., Zieverink W.D., Smilack J.D. Distribution of D-amino acid oxidase in bovine and human nervous tissues. J. Neurochem. 13:1966;163-166
31. Schell M.J., Molliver M.E., Snyder S.H. D-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3948-3952
32. Schell M.J., Brady R.O., Molliver M.E., Snyder S.H. D-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci. 17:1997;1604-1615
33. Snell K. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv. Enzyme Regul. 22:1984;325-400
34. Takahashi K., Hayashi F., Nishikawa T. In vivo evidence for the link between L- and D-serine metabolism in rat cerebral cortex. J. Neurochem. 69:1997;1286-1290
35. Tanii Y., Nishikawa T., Hashimoto A., Takahashi K. Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res. 563:1991;281-284
36. Tanii Y., Nishikawa T., Hashimoto A., Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 269:1994;1040-1048
37. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42:2002;165-179
38. Tsai G., Yang P., Chung L.C., Lange N., Coyle J.T. D-Serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry. 44:1998;1081-1089
39. Tsai G., Yang P., Chung L.C., Tsai I.C., Tsai C.W., Coyle J.T. D-Serine added to clozapine for the treatment of schizophrenia. Am. J. Psychiatry. 156:1999;1822-1825
40. Tsuchida H., Yamamoto N., Kajii Y., Umino A., Fukui K., Nishikawa T. Cloning of a D-serine-regulated transcript dsr-1 from the rat cerebral cortex. Biochem. Biophys. Res. Commun. 280:2001;1189-1196
41. Weimar W.R., Neims A.H. The development of D-amino acid oxidase in rat cerebellum. J. Neurochem. 29:1977;649-656
42. Wolosker H., Sheth K.N., Takahashi M., Mothet J.P., Brady R.O., Ferris C.D., Snyder S.H. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc. Natl. Acad. Sci. U. S. A. 96:1999;721-725
43. Wolosker H., Blackshaw S., Snyder S.H. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13409-13414